Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Larafen CR 200mg capsules
1001010L0BHAAAJ
|
Larafen | Ketoprofen | Musculoskeletal and Joint Diseases | 3 |
|
Larvae 100 30cm x 30cm dressing pack
1311070S0BBAWAA
|
LarvE | Ster larvae | Skin | 3 |
|
Laryvox tape comfort extra large oval
20050600022
|
Laryvox tape comfort extra large oval | Tracheostomy & Laryngectomy Appliances | Dressings | 3 |
|
Laryvox tape standard oval
20050600040
|
Laryvox tape standard oval | Tracheostomy & Laryngectomy Appliances | Dressings | 3 |
|
LentisCath catheter male 8Ch-18Ch
21020001605
|
LentisCath catheter male 8Ch-18Ch | Catheters | Appliances | 3 |
|
Letrozole 2.5mg/5ml oral suspension
0803041L0AAABAB
|
Letrozole | Letrozole | Malignant Disease and Immunosuppression | 3 |
|
Leukomed Control dressing 10cm x 24cm
20032400010
|
Leukomed Control dressing 10cm x 24cm | Wound Management & Other Dressings | Dressings | 3 |
|
Levitra 5mg tablets
0704050AABBAAAA
|
Levitra | Vardenafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3 |
|
Liberize 50mg tablets
0704050Z0BHAAAA
|
Liberize | Sildenafil (Erectile Dysfunction) | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3 |
|
Lidocaine 5% / Cetrimide 0.15% oromucosal gel sugar free
1502010J0AAETET
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 3 |
|
Lidocaine 5% gel
1502010J0AABVBV
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 3 |
|
Lidocaine 50mg/5ml (1%) inj Sure-Amp ampoules
1502010J0BLADBD
|
Sure-Amp Lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 3 |
|
Light Convex colostomy bag with filter opaque 25mm
23350703636
|
Light Convex colostomy bag with filter opaque 25mm | Colostomy Bags | Stoma Appliances | 3 |
|
Light White adhesive ileostomy bag large 44mm
23604106087
|
Light White adhesive ileostomy bag large 44mm | Ileostomy Bags | Stoma Appliances | 3 |
|
Light White adhesive ileostomy bag small 32mm
23604106089
|
Light White adhesive ileostomy bag small 32mm | Ileostomy Bags | Stoma Appliances | 3 |
|
Limisan Pro medical adhesive remover spray
23156501513
|
Limisan Pro medical adhesive remover spray | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 3 |
|
Linzagolix 100mg tablets
0607020Y0AAABAB
|
Linzagolix | Linzagolix | Endocrine System | 3 |
|
Lipistart powder
0913251A0BBAAAA
|
Lipistart powder infant formula | Powder infant formula (0913251) | Nutrition and Blood | 3 |
|
Liqua Care FlowGel diabetic orthotic insoles size 45-46
21290000131
|
Liqua Care FlowGel diabetic orthotic insoles size 45-46 | Pressure Offloading Device | Appliances | 3 |
|
Lo-Profile urostomy bag 25mm
23960109618
|
Lo-Profile urostomy bag 25mm | Urostomy Bags | Stoma Appliances | 3 |
|
Lofenoxal 2.5mg/25microgram tablets
0104020H0BGAAAA
|
Lofenoxal | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | 3 |
|
Mag-4 (magnesium 97.2mg (4mmol)) chewable tablets
0905013G0BCACDE
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
Mag-4 (magnesium 97.2mg (4mmol)) tablets
0905013G0BCADA2
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) caps
0905013G0AADBDB
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inj 5ml ampoules
0905013N0AAANAN
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | 3 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.